22 related articles for article (PubMed ID: 9713966)
1. Synergistic interactions between the synthetic retinoid tamibarotene and glucocorticoids in human myeloma cells.
Fukui T; Kodera Y; Nishio K; Masuda N; Tamura T; Koizumi F
Cancer Sci; 2009 Jun; 100(6):1137-43. PubMed ID: 19514122
[TBL] [Abstract][Full Text] [Related]
2. TENT5C/FAM46C modulation
Resnati M; Pennacchio S; Viviani L; Perini T; Materozzi M; Orfanelli U; Bordini J; Molteni R; Nuvolone M; Da Vià M; Lazzaroni F; Bolli N; Cenci S; Milan E
Haematologica; 2024 Jun; 109(6):1966-1972. PubMed ID: 38385303
[No Abstract] [Full Text] [Related]
3. Purging of myeloma cells using all-trans retinoic acid in a mouse model.
Henry JM; Morley AA; Sykes PJ
Exp Hematol; 2001 Mar; 29(3):315-21. PubMed ID: 11274759
[TBL] [Abstract][Full Text] [Related]
4. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
Taetle R; Dos Santos B; Akamatsu K; Koishihara Y; Ohsugi Y
Clin Cancer Res; 1996 Feb; 2(2):253-9. PubMed ID: 9816167
[TBL] [Abstract][Full Text] [Related]
5. All-trans retinoic acid modulates Fas antigen expression and affects cell proliferation and apoptosis in combination with anti-Fas monoclonal antibody in the human myeloma cell line, U266B1.
Okamura T; Masuda M; Arai Y; Ishida C; Shudou K; Mizoguchi H
Exp Hematol; 1998 Jun; 26(6):501-6. PubMed ID: 9620283
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 10 abolishes the growth inhibitory effects of all-trans retinoic acid on human myeloma cells.
Otsuki T; Yata K; Sakaguchi H; Kurebayashi J; Matsuo Y; Uno M; Fujii T; Eda S; Isozaki Y; Yawata Y; Yamada O; Wada H; Sugihara T; Ueki A
Br J Haematol; 2002 Mar; 116(4):787-95. PubMed ID: 11886382
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid inhibits the growth of human myeloma cells in vitro.
Palumbo A; Battaglio S; Napoli P; Bruno B; Omedè P; Boccadoro M; Pileri A
Br J Haematol; 1995 Mar; 89(3):555-60. PubMed ID: 7734354
[TBL] [Abstract][Full Text] [Related]
8. Effects of all-trans retinoic acid (ATRA) on human myeloma cells.
Otsuki T; Sakaguchi H; Hatayama T; Wu P; Takata A; Hyodoh F
Leuk Lymphoma; 2003 Oct; 44(10):1651-6. PubMed ID: 14692515
[TBL] [Abstract][Full Text] [Related]
9. IL-10 in myeloma cells.
Otsuki T; Yata K; Sakaguchi H; Uno M; Fujii T; Wada H; Sugihara T; Ueki A
Leuk Lymphoma; 2002 May; 43(5):969-74. PubMed ID: 12148907
[TBL] [Abstract][Full Text] [Related]
10. The use of animal models in multiple myeloma.
Libouban H
Morphologie; 2015 Jun; 99(325):63-72. PubMed ID: 25898798
[TBL] [Abstract][Full Text] [Related]
11. Differential in vitro and in vivo effects of all-trans retinoic acid on the growth of human myeloma cells.
Labaume S; Chopin M; Pla M; Brouet JC
Leuk Lymphoma; 1998 Jul; 30(3-4):361-6. PubMed ID: 9713966
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
